The Scientist

» funding and microbiology

Most Recent

Congress is not expected to fully enact the proposed cuts to research and public health programs.

1 Comment

image: Companies Pursue Diagnostics that Mine the Microbiome

Companies Pursue Diagnostics that Mine the Microbiome

By | May 23, 2017

Tests so far typically screen for risky patterns that may augment traditional types of clinical data.

0 Comments

National opinions about the effectiveness of last month’s science and climate marches are mixed and follow political lines, a Pew survey reports.

2 Comments

image: Zika's Economic Burden

Zika's Economic Burden

By | May 11, 2017

A new analysis estimates that the viral disease could cost between $183 million and more than $10 billion in the U.S. alone. 

1 Comment

Thirty percent of bacteria found in babies' guts came from mothers' milk, a study finds.

1 Comment

image: Warmer Temps Tied to Altered Microbiome in Lizards

Warmer Temps Tied to Altered Microbiome in Lizards

By | May 8, 2017

Bacterial differences after three-month temperature hikes, modeled after global warming predictions, were evident one year later, a study found.

1 Comment

If made law, the American Health Care Act passed today in the US House would eliminate the Obamacare-funded initiative.

0 Comments

image: Congress Agrees to Give NIH $2 Billion Extra

Congress Agrees to Give NIH $2 Billion Extra

By | May 1, 2017

The proposed spending plan for 2017 includes money for Alzheimer’s and cancer research.

1 Comment

image: Future Homes May Have Bioreactive Walls

Future Homes May Have Bioreactive Walls

By | May 1, 2017

Researchers are redesigning the humble brick to produce electricity, to clean water and air, and to harvest valuable compounds.

0 Comments

The giant lizards have numerous microbicidal compounds in their blood.

0 Comments

Popular Now

  1. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  2. Authors Peeved by APA’s Article Takedown Pilot
  3. Athletes’ Microbiomes Differ from Nonathletes
  4. Was a Drop in CRISPR Firms’ Stock Warranted?
AAAS